This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopad [2020/06/12 08:37] – [Conservation] rkoebnik | bacteria:t3e:xopad [2025/02/13 13:33] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopAD ====== | + | ====== |
- | Author: David Studholme\\ | + | Author: |
- | Internal reviewer: Laurent Noël\\ | + | Internal reviewer: |
- | Expert reviewer: FIXME | + | |
Class: XopAD\\ | Class: XopAD\\ | ||
Family: XopAD\\ | Family: XopAD\\ | ||
- | Prototype: XopAD (// | + | Prototypes: XAC4213 |
- | RefSeq | + | GenBank |
+ | GenBank | ||
+ | RefSeq ID: [[https:// | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 15: | Line 16: | ||
=== How discovered? === | === How discovered? === | ||
- | XopAD was discovered using a machine-learning approach (Teper //et al//., 2016). | + | XopAD was first described as a homologue of a type 3 effector from //Ralstonia solanacearum// |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
Line 21: | Line 22: | ||
=== Regulation === | === Regulation === | ||
- | Not known. | + | No PIP box was found in the promoter region of //xopAD// in //X. euvesicatoria// |
+ | |||
+ | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//), including //xopAD//, were significantly reduced in the // | ||
=== Phenotypes === | === Phenotypes === | ||
- | Deletion of //xopAD// does not alter //X. citri// pv. // | + | Deletion of //xopAD// does not alter //X. citri// pv. //citri// pathogenicity (Escalon //et al.//, 2013). |
=== Localization === | === Localization === | ||
Line 31: | Line 34: | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | Not known. However, the 614 amino acid protein consists of multiple [[https:// | + | Not known. However, the 614 amino acid protein consists of multiple [[https:// |
=== Interaction partners === | === Interaction partners === | ||
Line 40: | Line 43: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes. XopAD has homologues encoded in the genomes of most // | + | Yes. XopAD has homologues encoded in the genomes of most // |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
- | Yes. XopAD is homologous to members of the RipS1 family of effectors in //Ralstonia solanacearum// | + | Yes. XopAD is homologous to members of the RipS1 family of effectors in //Ralstonia solanacearum// |
===== References ===== | ===== References ===== | ||
Line 51: | Line 53: | ||
Harrison J, Studholme DJ (2014). Draft genome sequence of // | Harrison J, Studholme DJ (2014). Draft genome sequence of // | ||
- | Peeters N, Carrère S, Anisimova M, Plener L, Cazalé AC, Genin S (2013). Repertoire, unified nomenclature and evolution of the Type III effector gene set in the //Ralstonia solanacearum// | + | Liu Y, Long J, Shen D, Song C (2016). // |
+ | |||
+ | Peeters N, Carrère S, Anisimova M, Plener L, Cazalé AC, Genin S (2013). Repertoire, unified nomenclature and evolution of the type III effector gene set in the //Ralstonia solanacearum// | ||
Studholme DJ, Kemen E, MacLean D, Schornack S, Aritua V, Thwaites R, Grant M, Smith J, Jones JD (2010). Genome-wide sequencing data reveals virulence factors implicated in banana // | Studholme DJ, Kemen E, MacLean D, Schornack S, Aritua V, Thwaites R, Grant M, Smith J, Jones JD (2010). Genome-wide sequencing data reveals virulence factors implicated in banana // | ||
Line 60: | Line 64: | ||
Wasukira A, Tayebwa J, Thwaites R, Paszkiewicz K, Aritua V, Kubiriba J, Smith J, Grant M, Studholme DJ (2012). Genome-wide sequencing reveals two major sub-lineages in the genetically monomorphic pathogen // | Wasukira A, Tayebwa J, Thwaites R, Paszkiewicz K, Aritua V, Kubiriba J, Smith J, Grant M, Studholme DJ (2012). Genome-wide sequencing reveals two major sub-lineages in the genetically monomorphic pathogen // | ||
+ | |||
+ | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors of // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||
+ |